SDLN208 Worldwide Current AMR Commercially Organism Hospital Internet-based More than 200 n/a Website; surveillance funded by data resource of bacterial reports IHMA in vitro species, 100 antimicrobial antimicrobials susceptibility data 30 countries Current AMR Commercially Organism, Hospital and AMR trends of Bloodstream n/a Website, 52, 130, (reference surveillance funded by infection community common infection, provides 203, 204, laboratories BristolMyers populations pathogens mainly point 207, and Squibb causing HAI and prevalence outpatient respiratory tract information; (part of facilities; infections annual GAARD) including infections (S. reports, Australian H. sites) influenzae, M. catarrhalis), publications pneumonias, skin/soft tissue infections and urinary tract isolates; gastroenteritis pathogens and (since 2001) streptococcal isolates
SDLN208 Worldwide Current AMR surveillance Commercially funded by IHMA Organism Hospital Internet-based data resource of in vitro antimicrobial susceptibility data More than 200 bacterial species, 100 antimicrobials n/a Website; reports 52, 130, 203, 204, 207, (part of GAARD) 30 countries (reference laboratories and outpatient facilities; including Australian sites) Current AMR surveillance Commercially funded by BristolMyers Squibb Organism, infection Hospital and community populations AMR trends of common pathogens causing HAI and infections Bloodstream infection, respiratory tract infections (S. H. influenzae, M. catarrhalis), pneumonias, skin/soft tissue infections and urinary tract isolates; gastroenteritis pathogens and (since 2001) streptococcal isolates n/a Website, provides mainly point prevalence information; annual reports, publications
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx